<DOC>
	<DOCNO>NCT01770197</DOCNO>
	<brief_summary>The time window intravenous recombinant tissue plasminogen activator treatment ischemic stroke patient extend 4.5h . Little known intravenous recombinant tissue plasminogen activator use 3-4.5 hour time window among Chinese stroke patient . This exploratory study describe feasibility outcome treatment intravenous recombinant tissue plasminogen activator expand time window , offer suggestion future clinical work China .</brief_summary>
	<brief_title>Outcome Intravenous Thrombolysis Stroke Patients 3-4.5 Hour Time Window</brief_title>
	<detailed_description>Favorable clinical outcome intravenous recombinant tissue plasminogen activator assess absolute change National Institute Health Stroke Scale score 24 hour improvement modify Rankin Scale score discharge 6-month follow-up . The safety intravenous recombinant tissue plasminogen activator assess rate mortality , intracerebral hemorrhage common complication . Multivariate logistic regression model use evaluate factor associate favorable clinical outcome .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>stroke patient 34.5 hour time window stroke patient 4.5 hour time window</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>China</keyword>
	<keyword>Stroke</keyword>
	<keyword>Thrombolytic therapy</keyword>
</DOC>